Defilade Capital Management »

Biohaven shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 316k 8.46

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Biohaven

Henderson Group
BlackRock
Suvretta Capital Management
Stifel Financial
Infinitum Asset Management
State Street Corporation
TCG Crossover Management
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
FMR
Goldman Sachs Group
Balyasny Asset Management
Vanguard Portfolio Management
Susquehanna International

View all funds holding Biohaven